Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol

Gut. 2013 Jul;62(7):1044-54. doi: 10.1136/gutjnl-2012-303347. Epub 2012 Sep 29.

Abstract

Background: The hepatic endocannabinoid system and cytochrome P450 2E1 (CYP2E1), a key enzyme causing alcohol-induced reactive oxygen species (ROS) generation, are major contributors to the pathogenesis of alcoholic liver disease. The nuclear hormone receptor oestrogen-related receptor γ (ERRγ) is a constitutively active transcriptional activator regulating gene expression.

Objective: To investigate the role of ERRγ in the alcohol-mediated regulation of CYP2E1 and to examine the possibility to control alcohol-mediated oxidative stress and liver injury through an ERRγ inverse agonist.

Design: For chronic alcoholic hepatosteatosis study, C57BL/6J wild-type and CB1(-/-) mice were administered alcohol for 4 weeks. GSK5182 and chlormethiazole (CMZ) were given by oral gavage for the last 2 weeks of alcohol feeding. Gene expression profiles and biochemical assays were performed using the liver or blood of mice.

Results: Hepatic ERRγ gene expression induced by alcohol-mediated activation of CB1 receptor results in induction of CYP2E1, while liver-specific ablation of ERRγ gene expression blocks alcohol-induced expression of CYP2E1 in mouse liver. An ERRγ inverse agonist significantly ameliorates chronic alcohol-induced liver injury in mice through inhibition of CYP2E1-mediated generation of ROS, while inhibition of CYP2E1 by CMZ abrogates the beneficial effects of the inverse agonist. Finally, chronic alcohol-mediated ERRγ and CYP2E1 gene expression, ROS generation and liver injury in normal mice were nearly abolished in CB1(-/-) mice.

Conclusions: ERRγ, as a previously unrecognised transcriptional regulator of hepatic CB1 receptor, controls alcohol-induced oxidative stress and liver injury through CYP2E1 induction, and its inverse agonist could ameliorate oxidative liver injury due to chronic alcohol exposure.

Keywords: Alcohol-Induced Injury; Alcoholic Liver Disease; Gene Regulation; Liver; Liver Metabolism.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytochrome P-450 CYP2E1 / genetics
  • Cytochrome P-450 CYP2E1 / metabolism*
  • Cytochrome P-450 CYP2E1 Inhibitors
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Ethanol / pharmacology
  • Gene Expression Profiling / methods
  • Gene Expression Regulation, Enzymologic / drug effects
  • Gene Expression Regulation, Enzymologic / physiology
  • Liver / metabolism
  • Liver Diseases, Alcoholic / genetics
  • Liver Diseases, Alcoholic / metabolism*
  • Liver Diseases, Alcoholic / prevention & control
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Oxidation-Reduction
  • Oxidative Stress / physiology
  • Receptor, Cannabinoid, CB1 / physiology*
  • Receptors, Estrogen / deficiency
  • Receptors, Estrogen / genetics
  • Receptors, Estrogen / physiology*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Tamoxifen / analogs & derivatives
  • Tamoxifen / pharmacology
  • Tamoxifen / therapeutic use
  • Transcription, Genetic / physiology

Substances

  • Cytochrome P-450 CYP2E1 Inhibitors
  • Enzyme Inhibitors
  • Esrrg protein, mouse
  • GSK5182
  • Receptor, Cannabinoid, CB1
  • Receptors, Estrogen
  • Tamoxifen
  • Ethanol
  • Cytochrome P-450 CYP2E1